The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global DPT Vaccines Market Research Report 2025
Synopsis
The DPT vaccine or DTP vaccine is a class of combination vaccine against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus.
The global DPT Vaccines market was valued at US$ 5187.9 million in 2023 and is anticipated to reach US$ 6619.4 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
Global key DPT vaccines manufacturers include Sanofi Pasteur, GSK etc.The top 2 companies hold a share over 90%.Europe is the largest market, with a share about 34%, followed by North America and Asia-Pacific with the share about 27% and 25%.
This report aims to provide a comprehensive presentation of the global market for DPT Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DPT Vaccines.
Report Scope
The DPT Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global DPT Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Age, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DPT Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Age, and by regions.
Market Segmentation
By Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Segment by Type
DTaP
Tdap
DTwP
Segment by Age
12 Months Below
12 Months Above
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Age, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of DPT Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of DPT Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Age, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The DPT vaccine or DTP vaccine is a class of combination vaccine against three infectious diseases in humans: diphtheria, pertussis (whooping cough), and tetanus.
The global DPT Vaccines market was valued at US$ 5187.9 million in 2023 and is anticipated to reach US$ 6619.4 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
Global key DPT vaccines manufacturers include Sanofi Pasteur, GSK etc.The top 2 companies hold a share over 90%.Europe is the largest market, with a share about 34%, followed by North America and Asia-Pacific with the share about 27% and 25%.
This report aims to provide a comprehensive presentation of the global market for DPT Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding DPT Vaccines.
Report Scope
The DPT Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global DPT Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Age, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the DPT Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Age, and by regions.
Market Segmentation
By Company
Sanofi Pasteur
GSK
Mitsubishi Tanabe Pharma
KM Biologics
Wuhan Institute of Biological Products
Walvax Biotechnology
Chengdu Institute of Biological Products
Minhai Biotechnology
Segment by Type
DTaP
Tdap
DTwP
Segment by Age
12 Months Below
12 Months Above
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Age, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of DPT Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of DPT Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Age, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 DPT Vaccines Market Overview
1.1 Product Overview and Scope of DPT Vaccines
1.2 DPT Vaccines Segment by Type
1.2.1 Global DPT Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 DTaP
1.2.3 Tdap
1.2.4 DTwP
1.3 DPT Vaccines Segment by Age
1.3.1 Global DPT Vaccines Market Value by Age: (2024-2030)
1.3.2 12 Months Below
1.3.3 12 Months Above
1.4 Global DPT Vaccines Market Size Estimates and Forecasts
1.4.1 Global DPT Vaccines Revenue 2019-2030
1.4.2 Global DPT Vaccines Sales 2019-2030
1.4.3 Global DPT Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 DPT Vaccines Market Competition by Manufacturers
2.1 Global DPT Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global DPT Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global DPT Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global DPT Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of DPT Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of DPT Vaccines, Product Type & Application
2.7 DPT Vaccines Market Competitive Situation and Trends
2.7.1 DPT Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest DPT Vaccines Players Market Share by Revenue
2.7.3 Global DPT Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 DPT Vaccines Retrospective Market Scenario by Region
3.1 Global DPT Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global DPT Vaccines Global DPT Vaccines Sales by Region: 2019-2030
3.2.1 Global DPT Vaccines Sales by Region: 2019-2024
3.2.2 Global DPT Vaccines Sales by Region: 2025-2030
3.3 Global DPT Vaccines Global DPT Vaccines Revenue by Region: 2019-2030
3.3.1 Global DPT Vaccines Revenue by Region: 2019-2024
3.3.2 Global DPT Vaccines Revenue by Region: 2025-2030
3.4 North America DPT Vaccines Market Facts & Figures by Country
3.4.1 North America DPT Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America DPT Vaccines Sales by Country (2019-2030)
3.4.3 North America DPT Vaccines Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe DPT Vaccines Market Facts & Figures by Country
3.5.1 Europe DPT Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe DPT Vaccines Sales by Country (2019-2030)
3.5.3 Europe DPT Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific DPT Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific DPT Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific DPT Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific DPT Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America DPT Vaccines Market Facts & Figures by Country
3.7.1 Latin America DPT Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America DPT Vaccines Sales by Country (2019-2030)
3.7.3 Latin America DPT Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa DPT Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa DPT Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa DPT Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa DPT Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global DPT Vaccines Sales by Type (2019-2030)
4.1.1 Global DPT Vaccines Sales by Type (2019-2024)
4.1.2 Global DPT Vaccines Sales by Type (2025-2030)
4.1.3 Global DPT Vaccines Sales Market Share by Type (2019-2030)
4.2 Global DPT Vaccines Revenue by Type (2019-2030)
4.2.1 Global DPT Vaccines Revenue by Type (2019-2024)
4.2.2 Global DPT Vaccines Revenue by Type (2025-2030)
4.2.3 Global DPT Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global DPT Vaccines Price by Type (2019-2030)
5 Segment by Age
5.1 Global DPT Vaccines Sales by Age (2019-2030)
5.1.1 Global DPT Vaccines Sales by Age (2019-2024)
5.1.2 Global DPT Vaccines Sales by Age (2025-2030)
5.1.3 Global DPT Vaccines Sales Market Share by Age (2019-2030)
5.2 Global DPT Vaccines Revenue by Age (2019-2030)
5.2.1 Global DPT Vaccines Revenue by Age (2019-2024)
5.2.2 Global DPT Vaccines Revenue by Age (2025-2030)
5.2.3 Global DPT Vaccines Revenue Market Share by Age (2019-2030)
5.3 Global DPT Vaccines Price by Age (2019-2030)
6 Key Companies Profiled
6.1 Sanofi Pasteur
6.1.1 Sanofi Pasteur Corporation Information
6.1.2 Sanofi Pasteur Description and Business Overview
6.1.3 Sanofi Pasteur DPT Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pasteur DPT Vaccines Product Portfolio
6.1.5 Sanofi Pasteur Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK DPT Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GSK DPT Vaccines Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 Mitsubishi Tanabe Pharma
6.3.1 Mitsubishi Tanabe Pharma Corporation Information
6.3.2 Mitsubishi Tanabe Pharma Description and Business Overview
6.3.3 Mitsubishi Tanabe Pharma DPT Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Mitsubishi Tanabe Pharma DPT Vaccines Product Portfolio
6.3.5 Mitsubishi Tanabe Pharma Recent Developments/Updates
6.4 KM Biologics
6.4.1 KM Biologics Corporation Information
6.4.2 KM Biologics Description and Business Overview
6.4.3 KM Biologics DPT Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 KM Biologics DPT Vaccines Product Portfolio
6.4.5 KM Biologics Recent Developments/Updates
6.5 Wuhan Institute of Biological Products
6.5.1 Wuhan Institute of Biological Products Corporation Information
6.5.2 Wuhan Institute of Biological Products Description and Business Overview
6.5.3 Wuhan Institute of Biological Products DPT Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Wuhan Institute of Biological Products DPT Vaccines Product Portfolio
6.5.5 Wuhan Institute of Biological Products Recent Developments/Updates
6.6 Walvax Biotechnology
6.6.1 Walvax Biotechnology Corporation Information
6.6.2 Walvax Biotechnology Description and Business Overview
6.6.3 Walvax Biotechnology DPT Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Walvax Biotechnology DPT Vaccines Product Portfolio
6.6.5 Walvax Biotechnology Recent Developments/Updates
6.7 Chengdu Institute of Biological Products
6.6.1 Chengdu Institute of Biological Products Corporation Information
6.6.2 Chengdu Institute of Biological Products Description and Business Overview
6.6.3 Chengdu Institute of Biological Products DPT Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Chengdu Institute of Biological Products DPT Vaccines Product Portfolio
6.7.5 Chengdu Institute of Biological Products Recent Developments/Updates
6.8 Minhai Biotechnology
6.8.1 Minhai Biotechnology Corporation Information
6.8.2 Minhai Biotechnology Description and Business Overview
6.8.3 Minhai Biotechnology DPT Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Minhai Biotechnology DPT Vaccines Product Portfolio
6.8.5 Minhai Biotechnology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 DPT Vaccines Industry Chain Analysis
7.2 DPT Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 DPT Vaccines Production Mode & Process
7.4 DPT Vaccines Sales and Marketing
7.4.1 DPT Vaccines Sales Channels
7.4.2 DPT Vaccines Distributors
7.5 DPT Vaccines Customers
8 DPT Vaccines Market Dynamics
8.1 DPT Vaccines Industry Trends
8.2 DPT Vaccines Market Drivers
8.3 DPT Vaccines Market Challenges
8.4 DPT Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global DPT Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global DPT Vaccines Market Value Comparison by Age (2024-2030) & (US$ Million)
Table 3. Global DPT Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global DPT Vaccines Sales (M Doses) of Key Manufacturers (2019-2024)
Table 5. Global DPT Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global DPT Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global DPT Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market DPT Vaccines Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of DPT Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of DPT Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of DPT Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of DPT Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global DPT Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DPT Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global DPT Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global DPT Vaccines Sales by Region (2019-2024) & (M Doses)
Table 18. Global DPT Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global DPT Vaccines Sales by Region (2025-2030) & (M Doses)
Table 20. Global DPT Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global DPT Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global DPT Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global DPT Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global DPT Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America DPT Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America DPT Vaccines Sales by Country (2019-2024) & (M Doses)
Table 27. North America DPT Vaccines Sales by Country (2025-2030) & (M Doses)
Table 28. North America DPT Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America DPT Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe DPT Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe DPT Vaccines Sales by Country (2019-2024) & (M Doses)
Table 32. Europe DPT Vaccines Sales by Country (2025-2030) & (M Doses)
Table 33. Europe DPT Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe DPT Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific DPT Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific DPT Vaccines Sales by Region (2019-2024) & (M Doses)
Table 37. Asia Pacific DPT Vaccines Sales by Region (2025-2030) & (M Doses)
Table 38. Asia Pacific DPT Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific DPT Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America DPT Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America DPT Vaccines Sales by Country (2019-2024) & (M Doses)
Table 42. Latin America DPT Vaccines Sales by Country (2025-2030) & (M Doses)
Table 43. Latin America DPT Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America DPT Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa DPT Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa DPT Vaccines Sales by Country (2019-2024) & (M Doses)
Table 47. Middle East & Africa DPT Vaccines Sales by Country (2025-2030) & (M Doses)
Table 48. Middle East & Africa DPT Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa DPT Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global DPT Vaccines Sales (M Doses) by Type (2019-2024)
Table 51. Global DPT Vaccines Sales (M Doses) by Type (2025-2030)
Table 52. Global DPT Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global DPT Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global DPT Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global DPT Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global DPT Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global DPT Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global DPT Vaccines Price (US$/Dose) by Type (2019-2024)
Table 59. Global DPT Vaccines Price (US$/Dose) by Type (2025-2030)
Table 60. Global DPT Vaccines Sales (M Doses) by Age (2019-2024)
Table 61. Global DPT Vaccines Sales (M Doses) by Age (2025-2030)
Table 62. Global DPT Vaccines Sales Market Share by Age (2019-2024)
Table 63. Global DPT Vaccines Sales Market Share by Age (2025-2030)
Table 64. Global DPT Vaccines Revenue (US$ Million) by Age (2019-2024)
Table 65. Global DPT Vaccines Revenue (US$ Million) by Age (2025-2030)
Table 66. Global DPT Vaccines Revenue Market Share by Age (2019-2024)
Table 67. Global DPT Vaccines Revenue Market Share by Age (2025-2030)
Table 68. Global DPT Vaccines Price (US$/Dose) by Age (2019-2024)
Table 69. Global DPT Vaccines Price (US$/Dose) by Age (2025-2030)
Table 70. Sanofi Pasteur Corporation Information
Table 71. Sanofi Pasteur Description and Business Overview
Table 72. Sanofi Pasteur DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Sanofi Pasteur DPT Vaccines Product
Table 74. Sanofi Pasteur Recent Developments/Updates
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. GSK DPT Vaccines Product
Table 79. GSK Recent Developments/Updates
Table 80. Mitsubishi Tanabe Pharma Corporation Information
Table 81. Mitsubishi Tanabe Pharma Description and Business Overview
Table 82. Mitsubishi Tanabe Pharma DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Mitsubishi Tanabe Pharma DPT Vaccines Product
Table 84. Mitsubishi Tanabe Pharma Recent Developments/Updates
Table 85. KM Biologics Corporation Information
Table 86. KM Biologics Description and Business Overview
Table 87. KM Biologics DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. KM Biologics DPT Vaccines Product
Table 89. KM Biologics Recent Developments/Updates
Table 90. Wuhan Institute of Biological Products Corporation Information
Table 91. Wuhan Institute of Biological Products Description and Business Overview
Table 92. Wuhan Institute of Biological Products DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Wuhan Institute of Biological Products DPT Vaccines Product
Table 94. Wuhan Institute of Biological Products Recent Developments/Updates
Table 95. Walvax Biotechnology Corporation Information
Table 96. Walvax Biotechnology Description and Business Overview
Table 97. Walvax Biotechnology DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. Walvax Biotechnology DPT Vaccines Product
Table 99. Walvax Biotechnology Recent Developments/Updates
Table 100. Chengdu Institute of Biological Products Corporation Information
Table 101. Chengdu Institute of Biological Products Description and Business Overview
Table 102. Chengdu Institute of Biological Products DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Chengdu Institute of Biological Products DPT Vaccines Product
Table 104. Chengdu Institute of Biological Products Recent Developments/Updates
Table 105. Minhai Biotechnology Corporation Information
Table 106. Minhai Biotechnology Description and Business Overview
Table 107. Minhai Biotechnology DPT Vaccines Sales (M Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. Minhai Biotechnology DPT Vaccines Product
Table 109. Minhai Biotechnology Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. DPT Vaccines Distributors List
Table 113. DPT Vaccines Customers List
Table 114. DPT Vaccines Market Trends
Table 115. DPT Vaccines Market Drivers
Table 116. DPT Vaccines Market Challenges
Table 117. DPT Vaccines Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of DPT Vaccines
Figure 2. Global DPT Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global DPT Vaccines Market Share by Type in 2023 & 2030
Figure 4. DTaP Product Picture
Figure 5. Tdap Product Picture
Figure 6. DTwP Product Picture
Figure 7. Global DPT Vaccines Market Value Comparison by Age (2024-2030) & (US$ Million)
Figure 8. Global DPT Vaccines Market Share by Age in 2023 & 2030
Figure 9. 12 Months Below
Figure 10. 12 Months Above
Figure 11. Global DPT Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global DPT Vaccines Market Size (2019-2030) & (US$ Million)
Figure 13. Global DPT Vaccines Sales (2019-2030) & (M Doses)
Figure 14. Global DPT Vaccines Average Price (US$/Dose) & (2019-2030)
Figure 15. DPT Vaccines Report Years Considered
Figure 16. DPT Vaccines Sales Share by Manufacturers in 2023
Figure 17. Global DPT Vaccines Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest DPT Vaccines Players: Market Share by Revenue in 2023
Figure 19. DPT Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global DPT Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America DPT Vaccines Sales Market Share by Country (2019-2030)
Figure 22. North America DPT Vaccines Revenue Market Share by Country (2019-2030)
Figure 23. United States DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe DPT Vaccines Sales Market Share by Country (2019-2030)
Figure 26. Europe DPT Vaccines Revenue Market Share by Country (2019-2030)
Figure 27. Germany DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific DPT Vaccines Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific DPT Vaccines Revenue Market Share by Region (2019-2030)
Figure 34. China DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America DPT Vaccines Sales Market Share by Country (2019-2030)
Figure 44. Latin America DPT Vaccines Revenue Market Share by Country (2019-2030)
Figure 45. Mexico DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa DPT Vaccines Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa DPT Vaccines Revenue Market Share by Country (2019-2030)
Figure 50. Turkey DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE DPT Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of DPT Vaccines by Type (2019-2030)
Figure 54. Global Revenue Market Share of DPT Vaccines by Type (2019-2030)
Figure 55. Global DPT Vaccines Price (US$/Dose) by Type (2019-2030)
Figure 56. Global Sales Market Share of DPT Vaccines by Age (2019-2030)
Figure 57. Global Revenue Market Share of DPT Vaccines by Age (2019-2030)
Figure 58. Global DPT Vaccines Price (US$/Dose) by Age (2019-2030)
Figure 59. DPT Vaccines Value Chain
Figure 60. DPT Vaccines Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
